Editorial: implications and future perspectives of the increase in biologics use in paediatric inflammatory bowel disease

Stephanie A. Vuijk; Lissy de Ridder

doi:10.1111/apt.17243

Editorial: implications and future perspectives of the increase in biologics use in paediatric inflammatory bowel disease

Stephanie A. Vuijk
, Lissy de Ridder^*

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	1619-1620
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	56
Issue number	11-12
DOIs	https://doi.org/10.1111/apt.17243
Publication status	Published - Dec 2022

Bibliographical note

ACKNOWLEDGEMENT
Declaration of personal interests: S.A. Vuijk: TISKids study wassupported by ZonMw, Crocokids and an Investigator-Sponsored
Research Award from Pfizer. L. de Ridder: Collaboration with Abbvie, Lilly, Takeda, Janssen and Pfizer. Grant from ZonMw, ECCO, Pfizer.

Access to Document

10.1111/apt.17243

Cite this

@article{e57bdf2673ec46afa281596f83cdd595,

title = "Editorial: implications and future perspectives of the increase in biologics use in paediatric inflammatory bowel disease",

author = "Vuijk, \{Stephanie A.\} and \{de Ridder\}, Lissy",

note = "ACKNOWLEDGEMENT Declaration of personal interests: S.A. Vuijk: TISKids study wassupported by ZonMw, Crocokids and an Investigator-Sponsored Research Award from Pfizer. L. de Ridder: Collaboration with Abbvie, Lilly, Takeda, Janssen and Pfizer. Grant from ZonMw, ECCO, Pfizer.",

year = "2022",

month = dec,

doi = "10.1111/apt.17243",

language = "English",

volume = "56",

pages = "1619--1620",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "John Wiley \& Sons Inc.",

number = "11-12",

}

TY - JOUR

T1 - Editorial

T2 - implications and future perspectives of the increase in biologics use in paediatric inflammatory bowel disease

AU - Vuijk, Stephanie A.

AU - de Ridder, Lissy

N1 - ACKNOWLEDGEMENT Declaration of personal interests: S.A. Vuijk: TISKids study wassupported by ZonMw, Crocokids and an Investigator-Sponsored Research Award from Pfizer. L. de Ridder: Collaboration with Abbvie, Lilly, Takeda, Janssen and Pfizer. Grant from ZonMw, ECCO, Pfizer.

PY - 2022/12

Y1 - 2022/12

UR - https://www.scopus.com/pages/publications/85141471125

U2 - 10.1111/apt.17243

DO - 10.1111/apt.17243

M3 - Editorial

C2 - 36352749

AN - SCOPUS:85141471125

SN - 0269-2813

VL - 56

SP - 1619

EP - 1620

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 11-12

ER -

Editorial: implications and future perspectives of the increase in biologics use in paediatric inflammatory bowel disease

Bibliographical note

Access to Document

Other files and links

Cite this